Advanced DBS programming – Multiple Groups : 3yrs experience
Objective: To study the utility of multiple programme groups of DBS parameters in the parkinson disease patients following up in our hospital in the last…Analysis of the exclusion causes for deep brain stimulation in Parkinson’s Disease Center in southern Taiwan
Objective: To analyze why patients with Parkinson’s disease (PD) were excluded from candidate selection for subthalamic deep brain stimulation. Background: Subthalamic deep brain stimulation (STN-DBS)…Interleaved Stimulation for Freezing of Gait in Advanced Parkinson’s Disease: A Pilot Study
Objective: To assess the effect of Interleaved Stimulation (ILS) in patients receiving subthalamic nucleus-Deep Brain Stimulation (STN-DBS), with Freezing of gait (FOG) unresponsive to medication and conventional…Metabolomic biomarkers strongly differentiate PD from healthy controls (HCs) in BioFIND study* specimens
Objective: To determine if metabolomic analysis - untargeted profiling of small-molecule (<1.5 kDalton) biochemical constituents - can yield useful diagnostic biomarkers of PD using CSF…Relationship between the presence of colonic a-synuclein and MDS research criteria for prodromal PD in patients without manifest motor parkinsonism (PARCAS study)
Objective: The aim of the study was to assess the prevalence of prodromal PD based on the MDS research criteria in a population of patients…Evaluation of CSF cytokine profiles in people with Parkinson disease and age-matched controls.
Objective: To investigate the levels of cytokines in the cerebrospinal fluid of subjects with Parkinson disease (PD) and matched healthy controls. Background: Neuroinflammation is thought…Non-Invasive Assessment of Swallowing and Respiration Coordination in Early Parkinson’s Disease
Objective: To investigate swallowing and its coordination with respiration in patients with Parkinson’s disease. Background: Patients with Parkinson’s disease usually present with speech and swallowing…Design and discovery of 1,2,4 triazole derivatives as adenosine A2A receptor antagonist against parkinson’s disease
Objective: In the present study, we intended to develop novel 1,2,4 triazole as potent A(2A)AR antagonists against parkinson’s disease. Background: Parkinson’s disease (PD) is a…Treatment of secondary movement disorders related to midbrain cavernomas
Objective: To evaluate possible efficacy and safety of standard antiparkinsonian drugs (levodopa formulations, amantadine) in patients with symptomatic midbrain cavernomas (haemorhage and/or surgery) and secondary…Piperine potentiate the neuroprotective effect of quercetin against MPTP induced neurotoxicity in rats
Objective: (1) Quercetin is well tolerated bioflavonoid used as supplement for various disorders but problem is its low oral bioavailability and (2) Piperine is combined…
- « Previous Page
- 1
- …
- 294
- 295
- 296
- 297
- 298
- …
- 388
- Next Page »